- Nachrichtendetail
-
31.05.2024 07:04:41 - dpa-AFX: *REGENERON: FDA EXTENDS TARGET ACTION DATE OF SBLA FOR DUPIXENT FOR COPD PATIENTS WITH TYPE 2 INFLAMMATION BY THREE MONTHS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.179,310 | 16.08.24 22:15:00 | +3,980 | +0,34% | 1.179,170 | 1.889,560 | 1.175,000 | 1.179,310 |
